semaglutide april 22 On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding FDA declares end to Wegovy

Investigating the Evidence While Ozempic hair loss is not a documented side effect, various factors could explain why some users experience hair thinning while taking semaglutide

This constant stream of cortisol binds to receptors in abdominal tissue

When researchers got their hands on three illegal versions, they found that the counterfeit drugs had low-purity semaglutide, had dosages that exceeded the labeled amount, and one had signs of bacterial contamination

Physician-supervised GLP-1 therapy from a real clinic in Aptos, not a faceless app

Physical activity patterns : There is no official contraindication to exercise following GLP-1 injection, but some patients report feeling less energetic or experiencing mild nausea